FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancerNicla Lorito(University of Florence), Andrea Morandi(University of Florence)bioRxiv (Cold Spring Harbor Laboratory)July 3, 202310.1101/2023.06.30.547227Cited by 1SaveCiteExport RISWatch citationsRelated PapersTargeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts|Oncotarget|2016|33Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease|Cell Death and Disease|2025|20Estrogen-dependent TRX2 activation reverts oxidative stress and metabolic dysfunction associated to steatotic disease|Research Square|2024|0